Symbol="ACRV"
AssetType="Common Stock"
Name="Acrivon Therapeutics Inc. Common Stock"
Description="Acrivon Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the development of precision cancer medicines. The company is headquartered in Watertown, Massachusetts."
CIK="1781174"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="480 ARSENAL WAY, SUITE 100, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="269690000"
EBITDA="-39394000"
PERatio="None"
PEGRatio="None"
BookValue="7.32"
DividendPerShare="0"
DividendYield="0"
EPS="-1.68"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.142"
ReturnOnEquityTTM="-0.283"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.68"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="22.67"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="-"
EVToRevenue="-"
EVToEBITDA="-9.39"
Beta="None"
num_52WeekHigh="25.47"
num_52WeekLow="8.06"
num_50DayMovingAverage="12.7"
num_200DayMovingAverage="14.07"
SharesOutstanding="21926000"
DividendDate="None"
ExDividendDate="None"
symbol="ACRV"
open="13.14"
high="13.34"
low="12.11"
price="12.30"
volume="15070.00"
latest_trading_day="2023-07-05"
previous_close="13.15"
change="-0.85"
change_percent="-6.4639%"
aroon_positive_momentum_days="28"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="28"
Volume_recent_avg="62219"
Change_recent_avg="-0.08"
Delta_recent_avg="1.4"
Variance_recent_avg="0.7"
Change_ratio_recent_avg="-0.91"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="28"
Aroon_momentum_negative="70"
image_negative_thumbnail_id_1="92"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0084.jpeg"
image_negative_thumbnail_id_2="116"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0060.jpeg"
image_neutral_thumbnail_id_1="585"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0014.jpeg"
image_neutral_thumbnail_id_2="557"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_positive_thumbnail_id_1="650"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0058.jpeg"
image_positive_thumbnail_id_2="1001"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0163.jpeg"
image_professor_thumbnail_id_1="1198"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0032.jpeg"
image_professor_thumbnail_id_2="1191"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0025.jpeg"
